Gallic acid ameliorates hyperglycemia and improves hepatic carbohydrate metabolism in rats fed a high-fructose diet

Nutrition Research

Volumn 36, Issue 2, 2016, Pages 150-160

  Huang, Da Wei ^a   Chang, Wen Chang ^b   Wu, James Swi Bea ^b   Shih, Rui Wen ^c   Shen, Szu Chuan ^c  

^a CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

Author keywords

Carbohydrate metabolism; Gallic acid; High fructose diet; Hyperglycemia; Insulin resistance; Rat

Indexed keywords

6 PHOSPHOFRUCTOKINASE; C PEPTIDE; FRUCTOSAMINE; FRUCTOSE; FRUCTOSE BISPHOSPHATASE; FRUCTOSE BISPHOSPHATE ALDOLASE; GALLIC ACID; GLUCOSE TRANSPORTER 2; GLYCOGEN SYNTHASE; HEXOKINASE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PIOGLITAZONE; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; ANTIDIABETIC AGENT; ANTIOXIDANT; CARBOHYDRATE DIET; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOHYDRATE DIET; CARBOHYDRATE METABOLISM; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; FRUCTOSAMINE BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; GLYCOLYSIS; HEPATITIS; HYPERGLYCEMIA; INSULIN RESISTANCE; MALE; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; ADVERSE EFFECTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CELL LINE; COMPARATIVE STUDY; COMPLICATION; DIET THERAPY; DIETARY SUPPLEMENT; GENE EXPRESSION REGULATION; IMMUNOLOGY; LIVER CELL; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PATHOLOGY; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; C-PEPTIDE; CARBOHYDRATE METABOLISM; CELL LINE; DIABETES MELLITUS, TYPE 2; DIETARY CARBOHYDRATES; DIETARY SUPPLEMENTS; FRUCTOSAMINE; FRUCTOSE; GALLIC ACID; GENE EXPRESSION REGULATION; HEPATITIS; HEPATOCYTES; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MALE; MICE; OXIDATIVE STRESS; RATS, WISTAR;

EID: 84958046897     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2015.10.001     Document Type: Article

References (37)

1. World Health Organization [Accessed: 31 August 2015]. http://www.who.int/diabetes/en/index.html.
2. Basciano H., Fedrico L., Adeli K. Fructose, insulin resistance and metabolic dyslipidemia. Nutr Metab 2005, 2:1-14.
3. Lin S., Yang Z., Liu H., Tang L., Cai Z. Beyond glucose: metabolic shifts in responses to the effects of oral glucose tolerance test and the high-fructose diet in rats. Mol BioSyst 2011, 7:1537-1548.
4. Collison K.S., Saleh S.M., Bakheet R.H., Al-Rabiah R.K., Inglis A.L., Makhoul N.J., et al. Diabetes of the liver: the link between nonalcoholic fatty liver disease and HFCS-55. Obesity 2009, 17:2003-2013.
5. Pranprawit A., Heyes J.A., Molan A.L., Kruger M.C. Antioxidant activity and inhibitory potential of blueberry extracts against key enzymes relevant for hyperglycemia. J Food Biochem 2015, 39:109-118.
6. Punithavathi V.R., Stanely Mainzen Prince P., Kumar M.R., Selvakumari C.J. Antihyperglycaemic, antilipid peroxidative and antioxidant effects of gallic acid on streptozotocin induced diabetic Wistar rats. Eur J Pharmacol 2011, 650:465-471.
7. Patel S.S., Goyal R.K. Cardioprotective effects of gallic acid in diabetes-induced myocardial dysfunction in rats. Pharmacognosy Res 2011, 3:239-245.
8. Punithavathi V.R., Stanely Mainzen Prince P., Kumar M.R., Selvakumari C.J. Protective effects of gallic acid on hepatic lipid peroxide metabolism, glycoprotein components and lipids in streptozotocin-induced type II diabetic Wistar rats. J Biochem Mol Toxicol 2011, 25:68-76.
9. Patel J., Iyer A., Brown L. Evaluation of the chronic complications of diabetes in a high fructose diet in rats. Indian J Biochem Biophys 2009, 46:66-72.
10. Chang W.C., Shen S.C. Effect of water extracts from edible Myrtaceae plants on uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose in tumour necrosis factor-α-treated FL83B mouse hepatocytes. Phytother Res 2013, 27:236-243.
11. Matthews D.R., Hosker J.R., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
12. Marklund S., Marklund G. Involvement of superoxide anion radical in autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974, 47:469-474.
13. Abei H. Catalase. Methods of enzymatic Analysis 1983, 673-686. [Weinhein Deerfield beach FL: USA]. H.U. Bergmeyer (Ed.).
14. Paglia D.E., Valentine W.N. Studies on the qualitative characterization of erythrocyte peroxidase. J Lab Clin Med 1967, 70:159-169.
15. Latha R.C.R., Daisy P. Insulin-secretagogue, antihyperlipidemic and other protective effects of gallic acid isolated from Tewminalia bellerica Roxb. in streptozotocin-induced diabetic rats. Chem Biol Interact 2011, 189:112-118.
16. Huang D.W., Shen S.C., Wu J.S.B. Effects of caffeic acid and cinnamic acid on glucose uptake in insulin-resistant mouse hepatocytes. J Agric Food Chem 2009, 57:7687-7692.
17. Samuel V.T. Fructose induced lipogenesis: from sugar to fat to insulin resistance. Trends Endocrinol Metab 2011, 22:60-65.
18. Dhar A., Dhar I., Jiang B., Desai K.M., Wu L. Chronic methylglyoxal infusion by minipump causes pancreatic β-cell dysfunction and induces type 2 diabetes in Sprague-Dawley rats. Diabetes 2011, 60:899-908.
19. Rosenfalck A.M., Thorsby P., Kjems L., Birkeland K., Dejgaard A., Hanssen K.F., et al. Improved postprandial glycaemic control with insulin Aspart in type 2 diabetic patients treated with insulin. Acta Diabetol 2000, 37:41-46.
20. Liu F., Kim J., Li Y., Liu X., Li J., Chen X. An extract of Lagerstroemia speciosa L. has insulin-like glucose uptake-stimulatory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells. J Nutr 2001, 131:2242-2247.
21. Zhou Y.B., Zhang J., Cai Y., Teng X., Duan X.H., Song J.D., et al. Insulin resistance induces medial artery calcification in fructose-fed rats. Exp Biol Med 2012, 237:50-57.
22. Doda R.F. Diabetes mellitus. Clinical chemistry 1996, 613-641. Mosby Year Book, St Louis. L.A. Kaplan, J.P. Amadeo (Eds.).
23. Kinosian B., Glick H., Garland G. Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann Intern Med 1994, 121:641-647.
24. Dhalla N.S., Pierce G.N., Innes I.R., Beamish R.E. Pathogenesis of cardiac dysfunction in diabetes mellitus. Can J Cardiol 1985, 1:263-281.
25. Tomlison K.C., Gardiner S.M., Herdes R.A., Binnet T. Functional consequences of streptozotocin induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Rev 1992, 44:103-150.
26. Dong Q., Yang K., Wong S.M., O'Brien P.J. Hepatocyte or serum albumin protein carbonylation by oxidized fructose metabolites: glyceraldehyde or glycolaldehyde as endogenous toxins?. Chem Biol Interact 2010, 188:31-37.
27. Sameermahmood Z., Raji L., Saravanan T., Vaidya A., Mohan V., Balasubramanyam M. Gallic acid protects RINm5F β-cells from glucolipotoxicity by its antiapoptotic an insulin-secretagogue actions. Phytother Res 2010, 24:S83-S94.
28. Togashi N., Ura N., Higashiura K. The contribution of skeletal muscle tumor necrosis factor-alpha to insulin resistance and hypertension in fructose-fed rats. J Hypertens 2000, 18:1605-1610.
29. White M.F. Insulin signaling in health and disease. Science 2003, 302:1710-1711.
30. Saltiel A.R., Kanh C.R. Insulin signaling and the regulation of glucose and lipid metabolism. Nature 2001, 414:799-806.
31. Lietzke S.E., Bose S., Cronin T., Klarlund J., Chawal A., Czech M.P., et al. Structural basis of 3-phosphoinositide recognition by pleckstrin homology domains. Mol Cell 2000, 6:385-394.
32. Tzeng F.T., Shorong S.L., I-Min L. Myricetin ameliorates defective post-receptor insulin signaling via β-endorphin signaling in the skeletal muscles of fructose-fed rats. Evid Based Complement Altern Med 2011, 1-9.
33. Huang D.W., Shen S.C. Caffeic acid and cinnamic acid ameliorate glucose metabolism via modulating glycogenesis and gluconeogenesis in insulin-resistant mouse hepatocytes. J Funct Foods 2012, 4:358-366.
34. Panneerselvam R.S., Gocindaswamy S. Effect of sodium molybdate on carbohydrate metabolizing enzymes in alloxan-induced diabetic rats. J Nutr Biochem 2002, 13:21-26.
35. Silva D.D., Zancan P., Coelho W.S., Gomez L.S., Sola-Penna M. Metformin reverses hexokinase and 6-phosphofructo-1-kinase inhibition in skeletal muscle, liver and adipose tissue from streptozotocin-induced diabetic mouse. Arch Biochem Biophys 2010, 496:53-60.
36. Yamakoshi Y., Nagano T., Hu J.C., Yamakoshi F., Simmer J.P. Porcine dentin sialoprotein glycosylation and glycosaminoglycan attachments. BMC Biochem 2011, 3:1-13.
37. Ferre J.C., Favre C., Gomis R.R., Femandez-Novell J.M., Garica-Rocha M., de la Iglesia N., et al. Control of glycogen deposition. FEBS Lett 2003, 546:127-132.